Life Sciences
China
Contribution fromKing & Wood Mallesons
Life sciences and healthcare: PRC firms
FOCUS ON…
By Fangda Partners — 1. Introduction Since the end of 2023, the mergers and acquisitions (M&A) trend in China’s life sciences industry has garnered substantial interest. This trend was, notably, initiated by AstraZeneca’Read more
- 1More informationFangda Partners
- 1More informationGlobal Law Office
- 1More informationKing & Wood MallesonsClient satisfaction
- 1More informationZhong Lun Law Firm
- 3More informationAnJie Broad Law Firm
- 3More informationDacheng
- 3More informationFenXun Partners
- 3More informationJingtian & GongchengClient satisfaction
- 3More informationLlinks Law Offices
- 3More informationShihui Partners
- 3More informationTian Yuan Law FirmClient satisfaction
- 3DaHui Lawyers
- 4More informationAllBright Law Offices
- 4More informationCommerce & Finance Law Offices
- 4More informationJincheng Tongda & Neal
- 4ZSK Attorneys-at-Law
